scholarly journals Erratum: Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China

2019 ◽  
Vol 6 (8) ◽  
Author(s):  
Brittany L Kmush ◽  
Huan Yu ◽  
Shoujie Huang ◽  
Xuefeng Zhang ◽  
Ting Wu ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Antibody Persistence

Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient

2020 ◽  
Vol 52 (8) ◽  
pp. 926-927 ◽  
Author(s):  
M Casper ◽  
MC Reichert ◽  
J Rissland ◽  
F Grünhage ◽  
F Lammert
Keyword(s):  
Chronic Hepatitis ◽  
Virus Infection ◽  
Transplant Recipient ◽  
Liver Transplant ◽  
Hepatitis E Virus ◽  
Liver Transplant Recipient ◽  
Hepatitis E ◽  
Term Treatment ◽  
Long Term Treatment

scholarly journals Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China

2019 ◽  
Vol 6 (4) ◽  
Author(s):  
Brittany L Kmush ◽  
Huan Yu ◽  
Shoujie Huang ◽  
Xuefeng Zhang ◽  
Ting Wu ◽  
...  
Keyword(s):  
Hepatitis E Virus ◽  
Contraceptive Use ◽  
Natural Infection ◽  
Vaccine Trial ◽  
Hepatitis E ◽  
Phase Iii ◽  
Antibody Persistence ◽  
Injectable Contraceptive ◽  
And Gender

Abstract Background Hepatitis E virus (HEV) is of global significance. HEV is a common cause of acute hepatitis in China. One of the major unanswered questions about HEV is the persistence of antibodies after infection and vaccination. Methods We examined antibody persistence 6.5 years after HEV exposures through natural infection and vaccination. Ninety-seven vaccine recipients and 70 individuals asymptomatically infected with HEV enrolled in the phase III HEV239 vaccine trial in Dongtai, China, were revisited. Results Antibody loss was 23.4% (95% confidence interval [CI], 17.1%–30.5%), with a nonsignificantly higher percentage of loss among those naturally infected (30.0%; 95% CI, 19.6%–42.1%) than those vaccinated (18.6%; 95% CI, 11.4%–27.7%; P = .085). Age and gender were not associated with antibody persistence. Only 2 people (1.2%) self-reported medically diagnosed jaundice or hepatitis-like illness in the last 10 years, both of whom had persistent antibodies. Contact with a jaundice patient and injectable contraceptive use were marginally associated with loss of detectable anti-HEV antibodies (P = .047 and .082, respectively), whereas transfusion was marginally associated with antibody persistence (P = .075). Conclusions Antibody loss was more common among those naturally infected compared with those vaccinated. However, none of the characteristics examined were strongly associated with antibody loss, suggesting that factors not yet identified may play a more important role in antibody loss. Long-term postvaccination antibody persistence is currently unknown and will be an important consideration in the development of policies for the use of the highly efficacious HEV vaccine. ClinicalTrials.gov registration.  NCT01014845.

Trends in hepatitis E virus infection: Analyses of the long‐term screening of blood donors in Hokkaido, Japan, 2005–2019

Transfusion ◽  
2021 ◽  
Author(s):  
Hidekatsu Sakata ◽  
Keiji Matsubayashi ◽  
Juri Iida ◽  
Kenta Nakauchi ◽  
Shinichi Kishimoto ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Blood Donors ◽  
Hepatitis E

Severe course of Hepatitis E Virus infection in a patient with pre-existing autoimmune liver disease

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
S Schlosser ◽  
J Pflaum ◽  
K Weigand ◽  
JJ Wenzel ◽  
W Jilg ◽  
...  
Keyword(s):  
Liver Disease ◽  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Autoimmune Liver Disease

Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals

2005 ◽  
Vol 76 (4) ◽  
pp. 526-533 ◽  
Author(s):  
Takehiro Mitsui ◽  
Yukie Tsukamoto ◽  
Shigeru Suzuki ◽  
Chikao Yamazaki ◽  
Kazuo Masuko ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Healthy Individuals ◽  
Serum Samples ◽  
Molecular Studies

Clinical and virologic features of hepatitis E virus infection at a university hospital in Japan between 2000 and 2019

2020 ◽  
Vol 92 (12) ◽  
pp. 3572-3583
Author(s):  
Naoto Sato ◽  
Shunji Watanabe ◽  
Kouichi Miura ◽  
Naoki Morimoto ◽  
Yoshinari Takaoka ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
University Hospital

scholarly journals Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jean Joel Bigna ◽  
Abdou Fatawou Modiyinji ◽  
Jobert Richie Nansseu ◽  
Marie A. Amougou ◽  
Moise Nola ◽  
...  
Keyword(s):  
Systematic Review ◽  
Virus Infection ◽  
Hepatitis E Virus ◽  
Meta Analysis ◽  
Hepatitis E ◽  
In Pregnancy

First Serological Study of Hepatitis E Virus Infection in Backyard Pigs from Serbia

2010 ◽  
Vol 2 (2) ◽  
pp. 110-113 ◽  
Author(s):  
Diana Lupulovic ◽  
Sava Lazic ◽  
Jasna Prodanov-Radulovic ◽  
Nereida Jiménez de Oya ◽  
Estela Escribano-Romero ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Serological Study ◽  
Backyard Pigs

O105 MICE WITH HUMAN LIVERS AS A NEW MODEL OF HEPATITIS E VIRUS INFECTION AND PRECLINICAL DRUG EVALUATION

2014 ◽  
Vol 60 (1) ◽  
pp. S42-S43 ◽  
Author(s):  
M. Lutgehetmann ◽  
K. Giersch ◽  
L. Allweiss ◽  
A.W. Lohse ◽  
S. Polywka ◽  
...  
Keyword(s):  
Virus Infection ◽  
Hepatitis E Virus ◽  
Drug Evaluation ◽  
Hepatitis E ◽  
New Model ◽  
Human Livers

scholarly journals Acute hepatitis E virus infection in human immunodeficiency virus-positive men and women in Nepal: Not quite a rare entity

Hepatology ◽  
2016 ◽  
Vol 64 (3) ◽  
pp. 1006-1007 ◽  
Author(s):  
Birendra Prasad Gupta ◽  
Ananta Shrestha ◽  
Anurag Adhikari ◽  
Thupten Kelsang Lama ◽  
Binaya Sapkota
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Infection ◽  
Acute Hepatitis ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Rare Entity ◽  
Men And Women ◽  
Immunodeficiency Virus ◽  
Acute Hepatitis E
Sign in / Sign up

Export Citation Format

Share Document